Pavel Sokolovsky

under the microscope

under the microscope · Jul 2026

130% solar cells, kind of.

“The result is a measurable quantum yield of around 130%.” Not exactly 130% energy efficiency as the article title implies, it is 1.3 charge carriers harvested per photon, which is still pretty cool.. ~ learn more

under the microscope · Jul 2026

The first BCI company with a CE marked device for the restoration of detailed form vision.

“For decades, losing central vision to this disease meant losing the ability to read, recognize faces, and ultimately losing independence. There was no viable treatment. Now there is.” Science Corp. says PRIMA just launched commercially in Europe after receiving a CE mark, and NEJM-published trial results suggest it can restore functional central vision for some patients with geographic atrophy from age-related macular degeneration. ~ learn more

under the microscope · Jul 2026

Recent advances in Alzheimer’s disease.

“In this review, we summarize the most recent updates in AD research on pathologic disease mechanisms and therapeutic strategies, highlighting advancements in apolipoprotein E (APOE) biology, neuroimmunology, biomarker discovery, and initial experience with new disease-modifying therapies. These important discoveries are revolutionizing AD diagnosis and treatment and provide hope for a future where AD is not only treatable but also preventable.” ~ learn more

under the microscope · Jul 2026

CRISPR as a suicide pill for cancer cells.

“In bacteria, this CRISPR acts as a suicide pill, intentionally killing a cell that has been infected by a virus to prevent its spread.” Researchers reengineered that idea so once a cell shows a cancer specific mutant RNA signature, it triggers “chromatin shredding,” “slicing up all the genetic material inside that specific cell.” ~ learn more

under the microscope · Jul 2026

A frog gut microbe for attacking tumors.

“A single intravenous dose of Ewingella americana led to complete tumor elimination in 100% of treated animals, with no recurrence upon re-exposure to cancer cells.” It’s a preclinical mouse colorectal cancer result, but the mechanism is wild: a living bacterium that homes to hypoxic tumors and then triggers a broad immune response. ~ learn more

under the microscope · Jul 2026

Exhale longer, take more risks.

“Prolonged exhalation increased risky choices by enhancing reward sensitivity and elevating cardiac parasympathetic activity.” The authors show that a longer exhale shifts autonomic state toward parasympathetic dominance and that shift tracks stronger reward responses in two parts of the brain. ~ learn more

under the microscope · Jul 2026

A dividing cell from non-living parts.

“It’s a big step forward to this holy grail of making a living thing out of dead components.” Researchers packed lab-made biomolecules into a membrane, then watched the synthetic cell grow, copy DNA, and split, even though it still needs constant deliveries of supplies. ~ learn more

under the microscope · Jul 2026

Guy in garage lab testing a new Alzheimer’s drug.

“I designed and synthesized PAC-832 in a chemistry lab I built in my garage.” Douglas Yao walks through PAC-832, “the world’s first selective GalR1 antagonist,” plus why targeting galanin signaling might help Alzheimer’s and how tools like robotics and LLMs sped up the work. ~ learn more

under the microscope · Jul 2026

What if humans could regrow tissue?

“[The genes are] already there -- you just need to learn how to get them to behave the way you want.” Texas A&M researchers used a two-step sequence of growth factors to regrow mice digits. Their intervention pushes normal healing away from scarring and toward rebuilding bone, ligaments, and joint structures. ~ learn more

under the microscope · Jul 2026

The cancer Alzheimer’s disease paradox.

“paradoxically, the risk of AD in patients with cancer is reduced by 25–35%. Conversely, the risk of cancer in patients with AD is halved.” ~ learn more